News

Asianet Newsable on MSN20m
Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left'
CER-1236 is designed to engineer T cells with phagocytic, or target-cell "eating," functions alongside traditional ...
Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript
Good afternoon, and welcome, everyone, to the Beyond Air Financial Results Call for the Fiscal Quarter and Year Ended March 31, 2025. [Operator Instructions] And now I would like to turn the call over ...